Henry Ford Cancer — Detroit, Michigan

Henry Ford Cancer is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma.

Sponsors: Revolution Medicines, Inc., Adcentrx Therapeutics, Nimbus Saturn, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer?

Henry Ford Cancer has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer conducted?

Henry Ford Cancer has 5 clinical trials on record, with 4 currently active. Their work covers Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma.

Is Henry Ford Cancer accredited by Crixeo Health?

Yes — Henry Ford Cancer holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Henry Ford Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.